Fortress Biotech Inc share price logo

Fortress Biotech Inc Share Price

NASDAQ: FBIO

Small Cap

$2.78

-0.10

(-3.47%)

Live

as on

Fortress Biotech Inc Stock Performance

as on March 28, 2026 at 4:08 am IST

  • Day's High

    $2.78
    $2.87

    3.24%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.33
    $4.53
    downward going graph

    52.34%

    Downside

    62.95%

    Upside

    downward going graph

Fortress Biotech Inc share price movements today

Previous Close
$2.88
Open
$2.87
Volume
559.1K
Day's Low - High
$2.78 - $2.87
52 Week Low - High
$1.33 - $4.53

Fortress Biotech Inc Historical Returns

1 Month Return
-15.79 %
3 Month Return
-22.99 %
1 Year Return
+ 66.47 %
3 Year Return
-74.4 %
5 Year Return
-94.82 %

Fortress Biotech Inc Stock Fundamentals & Key Indicators

Check Fortress Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$90.6M

EPS (TTM)

0.315

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.1

EBITDA

-79.9M

Revenue (TTM)

62.3M

Profit Margin

6.40%

Return On Equity TTM

-205.29%

Fortress Biotech Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fortress Biotech Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Fortress Biotech Inc image
Fortress Biotech Inc
BUY$90.6M-94.82%NA6.40%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.6B140.85%141.078.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.6B111.4%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.6BNA114.765.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$79.2B58.67%18.0831.41%

Stock Returns calculator for Fortress Biotech Inc Stock including INR - Dollar returns

The Fortress Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Fortress Biotech Inc investment value today

Current value as on today

₹1,71,203

Returns

₹71,203

(+71.2%)

Returns from Fortress Biotech Inc Stock

₹60,694 (+60.69%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Fortress Biotech Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Fortress Biotech Inc. Average target price of $10.75

Fortress Biotech Inc Share Price Target

Get share price movements and forecasts by analysts on Fortress Biotech Inc.

What analysts predicted

74.14%UPSIDE

Target Price

$10.75

Current Price

$2.78

Analyzed by

11 Analysts

Target

$10.75

Fortress Biotech Inc target price $10.75, a slight upside of 74.14% compared to current price of $2.78. According to 11 analysts rating.

Fortress Biotech Inc Stock’s Investor Sentiment and Interest

Search interest for Fortress Biotech Inc Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:24% versus previous 30 day period

Fortress Biotech Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
17
34
19
13
14
14
15
13
16
17
Gross Profit
9
28
13
7
8
9
9
8
11
11
Operating Income
-50
-13
-19
-36
-27
-22
-27
-22
-36
-6
EBITDA
-52
-5
-25
-35
-26
-21
-21
-20
-8
12
Interest Expense
3
2
2
2
2
6
2
2
2
2
Depreciation
1
2
1
1
1
3
-1
1
1
1
Income Before Tax
-59
-10
-28
-39
-28
-26
-25
-24
-11
8
Income Tax Expense
-28
0
0
-1
-2
0
0
-
-
0
Net Income
-24
-5
-9
-15
-10
-12
-6
-10
15
5
Net Profit Margin
-142.51%
-14.52%
-46.52%
-118.32%
-73.50%
-87.96%
-44.74%
-80.55%
94.35%
33.18%

Fortress Biotech Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
16
187
26
36
45
68
75
84
57
Gross Profit
0
5
26
20
26
31
36
44
61
36
Operating Income
-50
-65
-89
-119
-110
-94
-188
-203
-142
-110
EBITDA
-52
-66
-88
-118
-88
-87
-146
-193
-135
-104
Interest Expense
1
3
7
10
11
15
15
13
12
9
Depreciation
-
-
3
2
4
5
6
9
8
4
Income Before Tax
-53
-71
-98
-130
-101
-102
-164
-213
-153
-120
Income Tax Expense
-3
-12
1
0
-49
0
0
0
0
0
Net Income
-48
-55
-66
-84
-39
-46
-64
-86
-60
-45
Net Profit Margin
-5611.59%
-334.31%
-35.65%
-313.02%
-109.09%
-102.03%
-94.06%
-114.30%
-71.75%
-79.75%

Fortress Biotech Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-10
-9
-39
-10
-26
-26
-24
-11
8
Operating Cash Flow
-16
-34
-25
-21
-20
-12
-19
-27
-6
Investing Cash Flow
4
0
-
-
-
-15
1
6
2
Financing Cash Flow
-2
43
27
14
2
25
52
4
15
Change in Cash
-14
6
2
-7
-17
-2
33
-16
11

Fortress Biotech Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-71
-99
-130
-101
-102
-164
-213
-154
-120
Operating Cash Flow
-45
-85
-98
-94
-83
-116
-179
-128
-80
Investing Cash Flow
-6
-41
18
20
-7
40
-22
-2
-15
Financing Cash Flow
42
150
50
146
172
148
75
32
70
Change in Cash
-9
27
-29
71
81
72
-127
-97
-24

Global Institutional Holdings in Fortress Biotech Inc

Funds
Holdings
Renaissance Technologies Corp
0.26%
Geode Capital Management, LLC
0.79%
Vanguard Group Inc
3.55%
Nantahala Capital Management, LLC
1.09%
Citadel Advisors Llc
0.42%
See all

Insights on Fortress Biotech Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, FBIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 13.13M → 17.63M (in $), with an average increase of 13.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 146.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, FBIO stock has moved down by -3.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 15.48M → 5.85M (in $), with an average decrease of 62.2% per quarter

About Fortress Biotech Inc

fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business expertise and drug development capabilities to help the fortress companies achieve their goals. additionally, the company will provide funding and management services to each of the fortress companies and from time to time the company and the fortress companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs.
OrganisationFortress Biotech Inc
Headquarters1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154
IndustryHealth Technology
CEODr. Lindsay Allan Rosenwald M.D.
E-voting on sharesClick here to vote

Key Management of Fortress Biotech Inc

Name

Title

Dr. Lindsay Allan Rosenwald M.D.

Executive Chairman, President & CEO

Dr. Xiaoqin Lu M.D.

Chief Strategy Officer

Mr. Michael S. Weiss Esq., J.D.

Executive Vice Chairman of Strategic Development & Director

Mr. Samuel Berry

General Counsel & Corporate Secretary

FAQs

What is Fortress Biotech Inc share price today?

Fortress Biotech Inc share price today is $2.78 as on . Fortress Biotech Inc share today touched a day high of $2.87 and a low of $2.78.

What is the 52 week high and 52 week low for Fortress Biotech Inc share?

Fortress Biotech Inc share touched a 52 week high of $4.53 on and a 52 week low of $1.33 on . Fortress Biotech Inc stock price today i.e. is trending at $2.78,which is 38.63% down from its 52 week high and 109.81% up from its 52 week low.

What is Fortress Biotech Inc's market capitalisation today?

Fortress Biotech Inc market capitalisation is $0.00T as on .

How to invest in Fortress Biotech Inc Stock (FBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Fortress Biotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fortress Biotech Inc Shares that will get you 0.5396 shares as per Fortress Biotech Inc share price of $2.78 per share as on March 27, 2026 at 10:38 pm IST.

What is the minimum amount required to buy Fortress Biotech Inc Stock (FBIO) from India?

Indian investors can start investing in Fortress Biotech Inc (FBIO) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Fortress Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Fortress Biotech Inc share’s latest price of $2.78 as on March 27, 2026 at 10:38 pm IST, you will get 3.5971 shares of Fortress Biotech Inc. Learn more about fractional shares .

What are the returns that Fortress Biotech Inc has given to Indian investors in the last 5 years?

Fortress Biotech Inc stock has given -94.82% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?